磷酸二酯酶-4抑制剂促进培养黑素细胞及三维皮肤等效模型中的色素细胞增殖与黑素化
白癜风是一种常见的慢性自身免疫性疾病,目前尚无 definitive 治愈方法。本研究利用原代人黑素细胞培养和三维共培养皮肤模型(MelanoDerm),探究了两种已知PDE4抑制剂(crisaborole和roflumilast)及新化合物PF-07038124的促增殖和促黑素生成潜力。结果显示,PDE4抑制剂处理与两种体外模型中黑素细胞增殖和黑素化增加相关,并上调培养黑素细胞中黑素生成基因和蛋白表达,且加入α-黑素细胞刺激激素后效应增强。
要点
- PDE4抑制剂促进黑素细胞增殖和黑素化。
- PDE4抑制剂上调黑素生成基因和蛋白表达。
- α-MSH可增强PDE4抑制剂的上述效应。
核心结论
- PDE4抑制剂在体外模型中促进黑素细胞增殖和黑素化,并上调黑素生成基因和蛋白表达,支持进一步评估PDE4抑制剂(联合或不联合α-MSH激动剂)治疗白癜风。
研究设计与样本
- 研究使用两种体外模型系统:原代人黑素细胞培养和三维共培养皮肤模型(MelanoDerm),并采用由分光光度法、黑素和增殖实验、免疫染色、Fontana-Masson染色、RT-qPCR、western blot和全转录组RNA测序组成的探索性测试平台。
主要发现
- PDE4抑制剂处理与两种体外模型中黑素细胞增殖和黑素化增加相关。
- PDE4抑制剂处理与培养黑素细胞中黑素生成基因和蛋白表达增加相关。
- 加入α-黑素细胞刺激激素后,PDE4抑制剂的上述效应增强。
临床怎么用
- PDE4抑制剂可能作为白癜风复色治疗的候选药物,值得进一步开展临床试验评估,可考虑联合α-MSH激动剂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vitiligo is a common chronic autoimmune disease characterized by white macules and patches of the skin, having a negative impact on patients' life and without any definitive cure at present. Identification of new compounds to reverse depigmentation is therefore a pressing need for this disease. The pharmacologic compounds phosphodiesterase-4 inhibitors (PDE4is) are small molecules with immunomodulatory properties used for treatment of inflammatory dermatoses. PDE4is have shown repigmentation effects in patients with vitiligo, in some case reports. We characterized the proliferative and melanogenic potential of 2 known PDE4is-crisaborole and roflumilast-and of a more recently designed compound, PF-07038124. We used 2 in vitro model systems-the primary human melanocyte culture and a 3-dimensional cocultured skin model (MelanoDerm)-with an exploratory testing platform composed of complementary assays (spectrophotometry, melanin and proliferation assays, immunostaining, Fontana-Masson staining, RT-qPCR, western blot, and whole-transcriptome RNA sequencing). We identified that treatment with PDE4is was associated with increased melanocyte proliferation and melanization in both in vitro models and with increase in the melanogenic genes and proteins expression in cultured melanocytes. These effects were found to be enhanced by addition of α-melanocyte-stimulating hormone. Our findings support the further evaluation of PDE4is with or without α-melanocyte-stimulating hormone agonists in vitiligo trials.
引用
- Goldstein NB, Berk ZBK, Tomb LC, et al. Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent Model. J Invest Dermatol. 2024. PMID: 39182565. doi:10.1016/j.jid.2024.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。